The team plans to accomplish this goal by expanding whole genome or exome sequencing for patients, using patient - derived cells to discover new disease mechanisms, and personalized
drug library screening.
Not exact matches
«The next step is
screening the Takeda
libraries to find a similar
drug that doesn't affect the human proteasome.
When researchers
screened a
library of more than 200
drugs and related compounds for activity against embryonal subtype tumor cells from three patients, the most promising results involved
drugs that increased oxidative stress in tumor cells.
Using a robotics - based
screening approach, researchers
screened a
library of 1,192 FDA - approved
drugs for any that suppressed tumors in the fly and identified several that improved overall survival.
Companies in the partnership supply compound
libraries and
drug discovery expertise to the effort, while academic partners contribute knowledge about the disease and facilities for
screens and assays.
As part of
drug discovery, one of the earlier stages is you take a huge
library of chemical compounds and you
screen them with an assay for malaria or TB and you see if that chemical compound kills the parasite or bacteria.
«It will allow us to
screen libraries of
drug compounds relatively quickly.
Specifically, the research team used a miniaturized, high - speed technology to
screen through sample
libraries of 2,816 compounds already approved by the US Food and
Drug Administration for other uses.
«After
screening a natural compound
library, we developed an unbiased look at combinations of nutrients that have a better effect on prostate cancer than existing
drugs,» says corresponding author Stefano Tiziani, assistant professor in the Department of Nutritional Sciences and Dell Pediatric Research Institute at UT Austin.
Robotized «high - throughput
screens» like this are a growing trend in
drug development as they can work through massive
libraries of candidate
drugs quickly and accurately in a day, as opposed to the months required by manual methods.
Seeking to exploit this weakness and develop a new class of antifungals, an international group of researchers
screened a synthetic
drug library for compounds that target the synthesis of fungal but not mammalian GlcCer.
The process of
drug discovery has been dominated in recent years by the
screening of large
libraries of structurally diverse small molecules for effects on target proteins associated with disease.
We are going to
screen a larger
library of chemicals to identify molecules that either boost or weaken NMD, which should help develop better and more targeted
drugs for treating ALS, muscular dystrophy and cystic fibrosis.»
It has assembled an extensive
library of commercially available compounds and natural products that can be
screened in seconds using its proprietary Avalanche tool to jumpstart its
drug discovery programs.
The facility maintains a small molecule
library of ~ 100,000
drug - like small molecules for high - throughput
screening and provides access to liquid handling robotics and a multilabel plate reader.
UniChem supports the integration of high - throughput
screening data on small molecules with chemical
libraries and chemical resources for
drug discovery and optimization.
The collaboration is based on expanding Pelago's CETSA technology capabilities and will enable
screening of large chemical
libraries for identification of novel chemical leads with high
drug potential.
Screen novel chemical compound
libraries to identify effective
drugs to treat active disease.
The self - renewable capacity of these cells, their ability to differentiate into several tissue progenitors (neural, mesenchymal stem cells...), and the possibility to work with mutated cell lines define human stem cells as a good basis for
screening compounds
libraries in order to discover new potential
drugs for monogenic diseases.
Researchers
screened a comprehensive
library of approved
drugs for anti-HCV activity and found a common over-the-counter allergy
drug that lowered HCV levels in infected mice.
Used in experiments to understand biological processes and diseases and as part of the initial
drug - discovery process, Tocris life science reagents include receptor ligands, ion channel modulators, enzyme inhibitors, caged compounds, fluorescent probes, and
screening libraries.
His previous work at IDRI has included investigations into the physiology of the M.tuberculosis (Mtb) cell wall, the development of an overexpression
library for high throughput target identification, and the development of target based high throughput
screens for potential
drug candidates against Mtb.
After developing and optimizing assays in - house, Gladstone scientists can transfer these assays to the SMDC or other external facilities to perform high - throughput
screening with large compound
libraries to identify potential
drugs that may lead to therapies.
Phenotypic
screening of small molecule
libraries using iPSC - based models to identify novel
drug candidates and disease mechanisms.
Targeting intracellular human thymidylate synthase in live cells, their pilot
screen identified all
drugs within the
library known to act on this enzyme.
Towards that goal, the Foundation invested heavily in essential
drug discovery assets like animal models and in vitro systems to
screen existing
drugs and compound
libraries.
The team
screened a small molecule compound
library and identify a
drug, which they call CLP257.